• The main objective of POPIX is to develop new methods for population modelling
    in several fields (pharmacology, toxicity, biology, agronomy, etc.)
  • Our key application is population PK/PD (pharmacokinetics/pharmacodynamics) modelling
  • We are a partner of the DDMoRe (Drug and Disease Model Resources) project, supported by the Innovative Medicines Initiative (IMI)
  • Several of the methods we have developed are implemented in the MONOLIX software
  • In 2011 the company LIXOFT was created to develop and promote MONOLIX and future model-based drug development products
  • LIXOFT and Inria have a research partnership which guarantees close collaboration and rapid technology transfer

Permanent link to this article: